21 Oct 2021
XVIVO presents interim report Januari-September 2021
Third quarter 2021 (Jul 1 – Sep 30)• Net sales amounted to SEK 54.9 million (42.7), corresponding to…
Read moreNews Tag: English
18 Oct 2021
Record for a donor heart outside the body using ground-breaking XVIVO technology
XVIVO is setting new standards in heart transplantation. In an ongoing clinical trial in Australia and New Zealand, a donor heart was preserved using Non Ischemic Heart Preservation technology for 7 hours and 18 minutes before successful transplantation into a 55-year-old man. By pushing the ideal time limit from less than 4 hours for traditional storage using ice to more than 7 hours using XVIVO’s technology, more lives will be saved.
Read more 07 Oct 2021
Conference call on Interim Report
Invitation to attend XVIVO’s conference call regarding the presentation of the interim report July – September 2021. The presentation will be held in English.
Read more 05 Oct 2021
Advance publication of interim report January-September 2021
For administrative reasons, XVIVO Perfusion (publ) has decided to advance the publication of the interim report for the…
Read more 30 Sep 2021
Nomination committee of XVIVO Perfusion AB (publ)
The following members have been appointed to XVIVO Perfusion’s nomination committee for the 2022 annual general meeting: Henrik…
Read more
